Back
Enpro, Inc. 10K Form
Buy
51
NPO
Enpro, Inc.
Last Price:
$262.65
Seasonality Move:
6.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | NPO/Enpro, Inc. Quarterly |
| 2023-10-31 | 10Q | NPO/Enpro, Inc. Quarterly |
| 2023-08-09 | 10Q | NPO/Enpro, Inc. Quarterly |
| 2023-05-02 | 10Q | NPO/Enpro, Inc. Quarterly |
| 2022-11-07 | 10Q | NPO/Enpro, Inc. Quarterly |
| 2022-08-02 | 10Q | NPO/Enpro, Inc. Quarterly |
Receive NPO News And Ratings
See the #1 stock for the next 7 days that we like better than NPO
NPO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.1B |
|---|---|
| Cash Flow: | $48.2M |
| Price / Cash Flow: | 35.55 |
| Annual Sales: | $73.29 |
| Price / Book: | 3.53 |
Profitability
| EPS (TTM): | 1.89850 |
|---|---|
| Net Income (TTM): | $40.5M |
| Gross Margin: | $487.5M |
| Return on Equity: | 2.72% |
| Return on Assets: | 1.63% |
Enpro, Inc. Earnings Forecast
Key Enpro, Inc. Financial Ratios
-
The Gross Profit Margin over the past 25 years for NPO is 42.64%.
-
The Selling, General & Administrative Expenses for NPO have been equal to 28.29% of Gross Profit Margin.
-
The Research & Development expenses have been 1.16% of Revenue.
-
The Interest Expense is 83.95% of Operating Income.
-
The Net Earning history of NPO is 3.54% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 11 years.
Enpro, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | NPO |
| CUSIP: | 29355X |
| Website: | enpro.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 2.32 |
| Quick Ratio: | 1.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 134.39 |
|---|---|
| Forward P/E Ratio: | 25.46 |
NPO Technical Analysis vs Fundamental Analysis
Buy
51
Enpro, Inc. (NPO)
is a Buy
Is Enpro, Inc. a Buy or a Sell?
-
Enpro, Inc. stock is rated a BuyThe current Enpro, Inc. [NPO] share price is $256.73. The Score for NPO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.